Walfs Pharma Private Limited

Walfs Pharma Private Limited - pharma in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
CIN U21003TN2023PTC159158 Incorporated 27 March 2023 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.11 Cr
▲ 26% YoY
Net loss · FY 2025
₹36.88 Lakh
Net margin -33.4%
EBITDA · FY 2025
-₹35.77 Lakh
EBITDA margin -32.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Walfs Pharma Private Limited

Data last updated:

Walfs Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 2023.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U21003TN2023PTC159158.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mahalingam Ramanan and Ramanan Uma Mageswari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net loss of ₹36.88 Lakh (net margin -33.4%) and EBITDA of -₹35.77 Lakh (EBITDA margin -32.4%).

Company details

CIN U21003TN2023PTC159158
Registration Number 159158
Incorporation Date 27 March 2023
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Walfs Pharma Private Limited's registered office is in Chennai, Tamil Nadu.

  • Registered Address
    No 78 Perambur High Road, Perambur, Chennai, Tamil Nadu, India – 600011
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Walfs Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Walfs Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Walfs Pharma Private Limited, buy the company report.

Financials of Walfs Pharma Private Limited

FY 2025 filings available

Walfs Pharma Private Limited reported revenue of ₹1.11 Cr (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹1.11 Cr ▲ 26%
Net loss · FY 2025
₹36.88 Lakh margin -33.4%
EBITDA · FY 2025
-₹35.77 Lakh margin -32.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 26%
EBITDA CAGR growth
1 year
▲ 10%

Revenue rose 26% in the latest year. EBITDA rose 10% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹35.77 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹36.88 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-32.4%
Net Profit Margin-33.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Walfs Pharma Private Limited, buy the company report.

Board of directors of Walfs Pharma Private Limited

Walfs Pharma has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mahalingam RamananDirector27 Mar 20233 Years 7 MonthsCurrent
Ramanan Uma MageswariDirector27 Mar 20233 Years 7 MonthsCurrent
Gorav GuptaDirector27 Mar 20233 Years 7 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Walfs Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Walfs Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Walfs Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Gorav Gupta was appointed as Director on 27 Mar 2023.

AGM
Walfs Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Walfs Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Gorav Gupta was appointed as Director.
Appointed
Mahalingam Ramanan was appointed as Director.
Appointed
Ramanan Uma Mageswari was appointed as Director.
Incorporation
27 Mar 2023
Walfs Pharma Private Limited was registered on 27 Mar 2023 with Roc Chennai & aged 3 years 7 months as per MCA records.

Frequently asked questions

Walfs Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 2023 (3+ years old) and is registered under CIN U21003TN2023PTC159158.

Walfs Pharma has 3 current directors:

The latest financial statements of Walfs Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Walfs Pharma is U21003TN2023PTC159158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Walfs Pharma was incorporated on 27 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chennai.

Gorav Gupta was appointed as Director on 27 Mar 2023. Mahalingam Ramanan was appointed as Director on 27 Mar 2023. Ramanan Uma Mageswari was appointed as Director on 27 Mar 2023.

The registered office of Walfs Pharma is at No 78 Perambur High Road, Perambur, Chennai, Tamil Nadu, India – 600011.

Walfs Pharma operates in the pharma industry, in the drug formulation and development segment.

Walfs Pharma can be reached at its registered office: No 78 Perambur High Road, Perambur, Chennai, Tamil Nadu, India – 600011.

Walfs Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.